CBTCabot Corporation

$74.96-1.5% 1Y

Is it growing?

Watch

Growth is fading: revenue shrinking (−5% year on year), earnings down −53% year on year, and operating margin narrowing (−3.0 points).

3 to watch
Revenue trend−5% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +3% a year.

Earnings trend−53% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction−3.0 points operating

Trailing-twelve-month operating margin, 13.7% now against 16.7% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbottom 9% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is CBT growing?

Cabot Corporation has grown revenue −3.8% a year over three years and 2.8% a year over five, with earnings per share compounding at −12%.

−3.8%

Revenue growth, 3-year annual rate · Specialty Chemicals median +3.3% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
+2.8%

Revenue growth, 5-year rate · −3.8% over three · growth has slowed since the five-year average

Earnings per share, 3-year rate
−12%

Earnings per share, 3-year rate · revenue −3.8% · earnings lagged revenue: the growth is costing something

Years of annual history on file
18

Years of annual history on file · FY2008 to FY2025, as filed

Details›
Revenue FY2021
$3.41B
Revenue FY2022
$4.32B
Revenue FY2023
$3.93B
Revenue FY2024
$3.99B
Revenue FY2025
$3.71B

Annual income statements as filed with the SEC.